The global pharmaceutical industry is undergoing a consolidation phase in order to combat price pressure, competition and patent cliffs. Innovation is of vital importance for steady growth of pharmaceutical companies. Pharmaceutical companies have been mainly dependent on a few blockbuster molecules. However,with rapid decline in research and development (R&D) productivity and non-conducive regulatory environment, companies need to find... View more

The global pharmaceutical industry is undergoing a consolidation phase in order to combat price pressure, competition and patent cliffs. Innovation is of vital importance for steady growth of pharmaceutical companies. Pharmaceutical companies have been mainly dependent on a few blockbuster molecules. However,with rapid decline in research and development (R&D) productivity and non-conducive regulatory environment, companies need to find different avenues of growth. The patent expiry of blockbuster drugs is expected to pave way for generics. Due to difference in genetic composition of varied individuals, innovation is becoming more complex.This is influencing players offering complementary products and services to collaborate for new product development.

There are four major factors that are impacting the value creation in pharmaceutical industry:

  • Market
    • Stress from patent expiries, niche marketing, and patient-centricity is challenging the growth plans of pharmaceutical companies. Moreover, in emerging markets, companies face strong competition from local players,who sell product at a much lower cost. To counter the same global companies need to significantly reduce their profit margins.
  • Technology
    • Rapid integration of healthcare and information technology is posing threat for current blockbuster drugs
    • Products based on new technologies offer superior properties and are more efficient as compared to existing products in the market
  • Regulation
    • There is constant price pressure from governments to meet demands of growing number of patients
    • Emerging markets have regulatory uncertainty, where decisions are made to protect the interests of the general population
    • Moreover, governments, especially in emerging economies are encouraging pharmaceutical companies to focus on preventive measures for diseases, which involves major investments
  • Innovation
    • Need for innovative products or therapies is rising constantly due to rising pressure of patent-cliff coupled with reducing profit margins
    • Identification of new bacterial and viral strains is driving the need for novel drugs

Demand for personalized medicines is increasing in order to ensure effective treatment of various diseases

Investments in R&D for oncology and NCDs are increasing globally in order to provide cost-effective solutions available to ailing patients.

Market Challenges

The industry is facing certain challenges such as patent cliff, cost pressure and regulatory uncertainties across the globe. This is hindering market growth to a certain extent. Moreover, regulatory authorities are becoming more stringent with the drug approval process. However, with respect to drugs for rare diseases, the FDA has offered a fast-track approval process. Moreover, demand for cost-effective treatment for chronic and non-communicable diseases such as diabetes, hypertension, thyroid disorder, obesity, and cancer is increasing. However, there is a dearth of strong products in the pipeline that offer better treatment option with fewer side effects. The fear of side effects and long-term treatment costs is encouraging patients to shift to alternative therapies.

Combating Challenges

Market players need to combat these challenges and keep their pace with the industry to sustain their market share. Mergers, acquisitions, and divestitures of products, companies or business division is a rapidly emerging trend in the market to combat prevalent challenges in the market.Companies are more focused in terms of therapy areas and hence, are divesting less focused therapy businesses. A good example is the swap deal between GSK and Novartis in 2015.

Moreover, pharmaceutical companies are investing in consumer health products,with increasing consumer’s health awareness and emerging trend of self-medication. These trends are encouraging pharmaceutical companies to enter the OTC market and leverage their brand equity among the doctors, chemists and consumers. Companies such as GlaxoSmithKline, Cipla, Pfizer, Merck, Sun Pharma, and Abbott have a focused division or subsidiary for consumer healthcare products and markets.

Moreover, to combat increasing cost pressure, companies are evolving their distribution channel. Establishing facilities or presence through collaboration in regional markets has helped companies meet local demand with reduced costs and delivery time. Emergence of e-pharmacy has resulted in creation of a separate team in the organization to service consumers ordering medicines online. Moreover, companies are connecting with consumers through social media, which helps improve brand visibility. The distribution channel has thus evolved significantly from the decade old channel consisting of only wholesalers and physical retail shops.

Patient-centricity

Patients are increasingly becoming well informed and organized, sometimes demanding for a particular product from prescribers. Therefore, companies need to be more patient-centric in their approach and provide quality care to consumers. Pharmaceutical companies are focusing on established direct to consumer distribution channels and establishing a more strong relationship with them. Moreover, companies are creating a good purchase experience for consumers through different offerings such as post-purchase medical services, engaging the patient through social media and events, and providing regular product alerts and refilling services.

Growth in Emerging Economies

The pharmaceutical industry is rapidly expanding in emerging economies such as Asia Pacific, Africa, and Latin America. These regions possess immense potential for growth of pharmaceutical companies, owing to inadequate access to medicines, growing population and increasing incidence of non-communicable diseases (NCDs). Besides, demand for contract research and manufacturing is also high in these regions. China and India are the largest emerging markets for CRO and CMO. Companies are highly dependent on China for API supply owing to low purchase cost. Overdependence on a single country can pose a challenge for the pharmaceuticals sector in the near future. Therefore, other emerging countries such as India, Brazil and South Africa are encouraging investments in their country. Besides, global companies are establishing their facilities in Asia Pacific, Middle East and Latin America regions to enable close monitoring and servicing of lucrative regional markets.

Conclusion

Pharmaceutical companies need to focus on an integrated, patient-centric, value-driven approach along with technology integration and strategic partnerships in order to capitalize on lucrative growth opportunities in the market. Major global players in the market include Pfizer Inc., Merck & Co., Inc., Bayer AG, GlaxoSmithKline plc., Sanofi, F. Hoffmann-La Roche AG, AstraZeneca plc. and Novartis AG.

There is a paradigm shift in process in the global pharmaceutical industry from product to a ‘Prodice’ (Product and Service) model, to offer affordable, accessible and quality care to patients.View less

Pharmaceutical Published Insights

Coherent Market Insights Pigmentation Disorders Treatment Market

Published Date : Apr 2024

Global pigmentation disorders treatment market is estimated to be valued at USD 7.33 Bn in 2024 and is expected to exhibit a CAGR of 9.1% during the forecast period (2024-2031). Pigmentation disorders refer to conditions characterized by changes in skin color that are... View more

Coherent Market Insights Animal Healthcare Market

Published Date : Apr 2024

The Europe animal healthcare market is estimated to be valued at USD 15,270.3 Mn in 2024 and is expected to exhibit a CAGR 5.1% during the forecast period (2024-2031). The animal healthcare market in Europe is expected to grow at a significant rate over the next decad... View more

Coherent Market Insights Animal Growth Promoters Performance Enhancers Market

Published Date : Apr 2024

The global animal growth promoters performance enhancers market is estimated to be valued at USD 17.33 Bn in 2024 and is expected to exhibit a CAGR of 5.9% during the forecast period (2024-2031). Animal growth promoters and performance enhancers refer to feed additive... View more

Coherent Market Insights Hemostasis Coagulation Analyzer Market

Published Date : Apr 2024

Global hemostasis/coagulation analyzer market is estimated to be valued at USD 4.36 Bn in 2024 and is expected to exhibit a CAGR of 5.8% during the forecast period (2024-2031). The hemostasis/coagulation analyzer market has been growing at a steady rate over the past ... View more

Coherent Market Insights Us Nasal Spray Market

Published Date : Apr 2024

The U.S. nasal spray market is estimated to be valued at USD 10.42 Bn in 2024, and is expected to exhibit a CAGR of 6.9% during the forecast period (2024-2031). The U.S. nasal spray market has been witnessing steady growth over the past few years due to rising prevale... View more

Coherent Market Insights Intravenous Ibuprofen Market

Published Date : Apr 2024

Global intravenous (IV) ibuprofen market is estimated to be valued at USD 6.91 Bn in 2024 and is expected to exhibit a CAGR of 7% during the forecast period (2024-2031). Intravenous (IV) ibuprofen is used for pain relief and fever reduction for several decades. As an ... View more

Coherent Market Insights Medical Nutrition Market

Published Date : Apr 2024

The global medical nutrition market is estimated to be valued at USD 13.91 Bn in 2024 and is expected to exhibit a CAGR of 5.4% during the forecast period (2024-2031). The medical nutrition market has seen significant growth over the past decade driven by the increasi... View more

Coherent Market Insights Us Contract Research Organizations Market

Published Date : Apr 2024

The U.S. contract research organization (CROs) market is estimated to be valued at USD 19.44 Bn in 2024 and is expected to exhibit a CAGR of 12.2% during the forecast period (2024-2031). The U.S. Contract Research Organization (CROs) market has seen significant growth... View more

Coherent Market Insights Canine Atopic Dermatitis Treatment Drugs Market

Published Date : Apr 2024

The global canine atopic dermatitis treatment drugs market is estimated to be valued at USD 1,494.4 Mn in 2024 and is expected to exhibit a CAGR of 10.1% during the forecast period (2024-2031). Canine atopic dermatitis is a chronic skin condition observed in domestic ... View more

Coherent Market Insights Cancer Therapy Market

Published Date : Apr 2024

The global cancer therapy market is estimated to be valued at USD 205.10 Bn in 2024 and is expected to exhibit a CAGR of 12.4% during the forecast period (2024-2031). Cancer continues to pose significant healthcare challenges worldwide. Rapidly aging population profil... View more

Coherent Market Insights Trenbolone Enanthate Market

Published Date : Apr 2024

Global trenbolone enanthate market is estimated to be valued at USD 75.6 Mn in 2024 and is expected to exhibit a CAGR of 2.8% during the forecast period (2024-2031). Trenbolone Enanthate is an androgen and anabolic steroid, which is the 17β-enanthate ester of tre... View more

Coherent Market Insights Medical Tourism Market

Published Date : Apr 2024

The medical tourism market is estimated to be valued at USD 14.56 Bn in 2024, growing at a compound annual growth rate (CAGR) of 13.2% from 2024 to 2031. Medical tourism refers to the practice of traveling across international borders to obtain private medical care. R... View more

Coherent Market Insights Cancer Immunotherapy Market

Published Date : Apr 2024

Global cancer immunotherapy market is estimated to be valued at USD 141.06 Bn in 2024 and is expected to exhibit a CAGR of 12.1% during the forecast period (2024-2031). Cancer immunotherapy is a type of cancer treatment that utilizes the body's own immune system to fi... View more

Coherent Market Insights Liposome Drug Delivery Market

Published Date : Apr 2024

The global liposome drug delivery market is estimated to be valued at USD 5,482.2 Mn in 2024 and is expected to exhibit a CAGR of 8.9% during the forecast period (2024-2031). Liposome drug delivery is a promising approach for targeted drug delivery and release. Liposo... View more

Coherent Market Insights Vinpocetine Supplements Market

Published Date : Apr 2024

The global vinpocetine supplements market is estimated to be valued at USD 281.4 Mn in 2024 and is expected to exhibit a CAGR of 4.1% during the forecast period (2024-2031). Vinpocetine is a synthetic derivative of the alkaloid vincamine, which is extracted from the l... View more

Coherent Market Insights Multi Dose Drug Vial Adapters Market

Published Date : Apr 2024

The global multi dose drug vial adapters market is estimated to be valued at US$ 1,104.1 Mn in 2024 and is expected to exhibit a CAGR of 6.9% during the forecast period (2024-2031). Multi dose drug vial adapters are devices that allow the safe administration of medica... View more

Coherent Market Insights Dyspareunia Treatment Market

Published Date : Apr 2024

The global dyspareunia treatment market is estimated to be valued at USD 754.1 Mn in 2024 and is expected to exhibit a CAGR of 4.6% during the forecast period (2024-2031). Dyspareunia, or painful sexual intercourse, is a prevalent issue that affects women globally. It... View more

Coherent Market Insights Eyelash Serum Market

Published Date : Apr 2024

The global eyelash serum market is estimated to be valued at USD 936.3 Mn in 2024 and is expected to exhibit a CAGR of 5.5% during the forecast period (2024-2031). The global eyelash serum market has been witnessing a steady rise in recent years owing to the increasin... View more

LogoCredibility and Certifications

Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.

© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.